|
WO2021050524A1
|
|
Methods and compositions for delivering compact lyophilized agents for dissolving in a closed system
|
|
WO2020185846A1
|
|
Detection of double stranded nucleic acids in situ and methods related thereto
|
|
EP3781949A1
|
|
Methods and kits for detecting o-glcnac sites using b3galnt2 and ogt
|
|
WO2019199643A1
|
|
Methods to further enhance signal amplification for the in situ detection of nucleic acids
|
|
US2020362031A1
|
|
Compounds that modulate the interaction of vista and vsig3 and methods of making and using
|
|
CA3075676A1
|
|
Wnt/sfrp complexes, wnt-containing compositions, wnt-expressing cells, and methods of making, purifying, and using same
|
|
EP3645042A2
|
|
Hybridoma clones, monoclonal antibodies to vsig-4, and methods of making and using
|
|
US2018354703A1
|
|
Dual chamber storage device
|
|
US2020055911A1
|
|
Il-37 fusion protein and methods of making and using same
|
|
US2018149658A1
|
|
Methods and kits for cancer antigen and heparan sulfate imaging
|
|
WO2018067449A1
|
|
Methods and kits for assaying endoglycosidase activity
|
|
WO2018027042A1
|
|
Identification of vsig3/vista as a novel immune checkpoint and use thereof for immunotherapy
|
|
US2019285624A1
|
|
Surface plasmon resonance sensor chip having sensor surface capable of capturing multiple species of antibodies and method of making
|
|
US2016068884A1
|
|
Methods for determining presence or absence of glycan epitopes on glycoproteins
|
